Nerlynx approved in Europe as extended adjuvant therapy of HER2-positive early-stage breast cancer Sep. 5, 2018
Boehringer Ingelheim and Tsinghua University to develop novel therapies against infectious diseases Sep. 5, 2018
Additional positive data presented from phase IIa study of NasoVAX intranasal influenza vaccine Sep. 5, 2018
Medications for alcohol or opioid use disorders may reduce suicidal behavior and criminality Sep. 5, 2018
Selective nonlethal mechanism-based inhibitors of gut microbial TMAO reduce thrombosis potential Sep. 5, 2018
RSS